Neisseria Meningitidis Serogroup B
2 clinical trials · Condition
◉ Watch Neisseria Meningitidis Serogroup B
| Record | Firm | Date |
|---|---|---|
| A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104 (NCT07395739) | Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks) | 2026-03-20 |
| Meningococcal B Vaccination in University Students (NCT00443157) | Public Health England | 2006-02-01 |
Track Neisseria Meningitidis Serogroup B automatically
Every clearance here is in the API, with alerts when new ones post.